It, too, is being studied along with inhaled insulin as an Alzheimer treatment
SOUL: CVOT 13 Study design: A randomized, international, double-blind, parallel-group, placebo-controlled, event-driven, superiority phase 3b trial in adults with T2D and established atherosclerotic cardiovascular disease, CKD, or both
The content may contain typographical errors, omissions, or outdated information
Switching from Semaglutide to Tirzepatide Reasons for Making the Switch Several reasons might motivate a patient to switch from Semaglutide to Tirzepatide: Weight Loss Plateau : If youve been using Semaglutide for weight loss but feel like youve hit a plateau, Tirzepatide could offer a new chance for further weight reduction